Atria Wealth Solutions’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Sell |
3,443
-3,219
| -48% | -$252K | 0.01% | 1210 |
|
|
2025
Q1 | $483K | Sell |
6,662
-29,763
| -82% | -$2.16M | 0.01% | 1207 |
|
|
2024
Q4 | $2.7M | Sell |
36,425
-321
| -0.9% | -$23.8K | 0.03% | 538 |
|
|
2024
Q3 | $2.42M | Sell |
36,746
-10,072
| -22% | -$665K | 0.03% | 557 |
|
|
2024
Q2 | $4.32M | Buy |
46,818
+939
| +2% | +$86.7K | 0.05% | 372 |
|
|
2024
Q1 | $4.38M | Buy |
45,879
+863
| +2% | +$82.5K | 0.05% | 374 |
|
|
2023
Q4 | $3.43M | Sell |
45,016
-92
| -0.2% | -$7.02K | 0.04% | 416 |
|
|
2023
Q3 | $3.13M | Sell |
45,108
-2,405
| -5% | -$167K | 0.04% | 422 |
|
|
2023
Q2 | $4.48M | Sell |
47,513
-12,033
| -20% | -$1.14M | 0.06% | 313 |
|
|
2023
Q1 | $4.93M | Sell |
59,546
-986
| -2% | -$81.6K | 0.07% | 269 |
|
|
2022
Q4 | $4.52M | Sell |
60,532
-3,528
| -6% | -$263K | 0.07% | 272 |
|
|
2022
Q3 | $5.29M | Buy |
64,060
+18,893
| +42% | +$1.56M | 0.09% | 222 |
|
|
2022
Q2 | $4.3M | Buy |
45,167
+7,500
| +20% | +$713K | 0.08% | 244 |
|
|
2022
Q1 | $4.43M | Buy |
+37,667
| New | +$4.43M | 0.07% | 276 |
|